Trial Profile
Phase II trial of lansoprazole [PrevOnco; NexMed] and doxorubicin as first-line therapy in patients with advanced unresectable liver cancer.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 24 Feb 2011
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary) ; Doxorubicin
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Apricus Biosciences
- 31 Mar 2010 New trial record